|
|
Boston Scientific Corporation (BSX) |
|
|
|
| |
BSX's Revenue Growth by Quarter and Year
Boston Scientific's Revenue results by quarter and year
|
Select the Comparisons :
|
|
Select the Ratio:
|
|
| BSX Revenue (in millions $) |
FY 2023 |
FY 2022 |
FY 2021 |
FY 2020 |
| IV Quarter |
December |
-
|
3,243.00
|
3,127.00
|
2,708.00
|
| III Quarter |
September |
-
|
3,170.00
|
2,932.00
|
2,659.00
|
| II Quarter |
June |
3,600.00
|
3,244.00
|
3,077.00
|
2,003.00
|
| I Quarter |
March |
3,389.00
|
3,026.00
|
2,752.00
|
2,543.00
|
| FY |
|
6,989.00
|
12,683.00
|
11,888.00
|
9,913.00
|
| BSX Revenue second quarter 2023 Y/Y Growth Comment |
Boston Scientific Corporation achieved in the second quarter 2023, above Company average Revenue increase of 10.97% year on year, to $ 3,600.00 millions.
Looking into second quarter 2023 results within Medical Equipment & Supplies industry 35 other companies have achieved higher Revenue growth. While Boston Scientific Corporation' s Revenue growth of 10.97% ranks overall at the positon no. 951 in the second quarter 2023.
|
| BSX Revenue ( Y/Y Growth %) |
2023
|
2022 |
2021 |
2020 |
| IV Quarter |
December |
- |
3.71 % |
15.47 % |
-49.83 % |
| III Quarter |
September |
- |
8.12 % |
10.27 % |
-1.77 % |
| II Quarter |
June |
10.97 % |
5.43 % |
53.62 % |
-23.87 % |
| I Quarter |
March |
12 % |
9.96 % |
8.22 % |
-0.78 % |
| FY |
|
- |
6.69 % |
19.92 % |
-25.46 % |
BSX Revenue (Quarter on Quarter Growth %) |
2023
|
2022 |
2021 |
2020 |
| IV Quarter |
December |
- |
2.3 % |
6.65 % |
1.84 % |
| III Quarter |
September |
- |
-2.28 % |
-4.71 % |
32.75 % |
| II Quarter |
June |
6.23 % |
7.2 % |
11.81 % |
-21.23 % |
| I Quarter |
March |
4.5 % |
-3.23 % |
1.62 % |
-52.89 % |
| FY (Year on Year) |
|
- |
6.69 % |
19.92 % |
-25.46 % |
| Revenue Y/Y Growth Statistics |
| High |
Average |
Low |
| 71.7 % |
6.25 % |
-25.07 % |
| (Dec 31 2013) |
|
(Dec 31 2020) |
|
|
| Revenue Y/Y Growth Statistics |
| High |
Average |
Low |
| 71.7 % |
6.25 % |
-25.07 % |
| (Dec 31 2013) |
|
(Dec 31 2020) |
|
| Revenue by Quarter for the Fiscal Years 2020, 2021, 2022, 2023 |
Boston Scientific's Q/Q Revenue Growth
| Revenue Q/Q Growth Statistics |
| High |
Average |
Low |
| 99.41 % |
2.7 % |
-52.89 % |
| (Dec 31 2019) |
|
|
| BSX's II. Quarter Q/Q Revenue Comment |
Boston Scientific Corporation achieved in the II. Quarter 2023 above company average sequential Revenue increase of 6.23%, to $ 3,600.00 millions, from $3,389.00 millions in the first quarter.
Within Medical Equipment & Supplies industry 90 other companies have achieved higher Revenue quarter on quarter growth. While Boston Scientific's Revenue growth quarter on quarter, overall rank is 1350. |
|
|
|
| Revenue Q/Q Growth Statistics |
| High |
Average |
Low |
| 99.41 % |
2.7 % |
-52.89 % |
| (Dec 31 2019) |
|
|
| BSX's II. Quarter Q/Q Revenue Comment |
Boston Scientific Corporation achieved in the II. Quarter 2023 above company average sequential Revenue increase of 6.23%, to $ 3,600.00 millions, from $3,389.00 millions in the first quarter.
Within Medical Equipment & Supplies industry 90 other companies have achieved higher Revenue quarter on quarter growth. While Boston Scientific's Revenue growth quarter on quarter, overall rank is 1350. |
|
Boston Scientific's 12 Months Revenue Growth Year on Year
Revenue TTM Growth |
12 Months Ending
(Jun 30 2023) |
12 Months Ending
(Mar 31 2023) |
12 Months Ending
(Dec 31 2022) |
12 Months Ending
(Sep 30 2022) |
12 Months Ending
(Jun 30 2022) |
| Cumulative Revenue 12 Months Ending |
$ 13,402.00 |
$ 13,046.00 |
$ 12,683.00 |
$ 12,567.00 |
$ 12,329.00 |
| Y / Y Revenue Growth (TTM) |
8.7 % |
7.27 % |
6.69 % |
9.57 % |
10.12 % |
| Year on Year Revenue Growth Overall
Ranking |
# 703 |
# 978 |
# 852 |
# 1007 |
# 1126 |
| Seqeuential Revenue Change (TTM) |
2.73 % |
2.86 % |
0.92 % |
1.93 % |
1.37 % |
| Seq. Revenue Growth (TTM) Overall
Ranking |
# 951 |
# 2342 |
# 1827 |
# 1026 |
# 2444 |
| Cumulative Revenue growth
Comment |
Boston Scientific saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 8.7% year on year, to $ 13,402 millions if the fiscal year would have ended in Jun 30 2023.
Boston Scientific's trailing twelve months Revenue growth was higher than company's average 6.25% and higher than 7.27% growth in Mar 31 2023.
But from twelve months ended Mar 31 2023 growth rate was slower at 2.73 % from $13046 millions achieved in the period from Mar 31 2023 to Jun 30 2022 Matteo Mancini added on.
It appears to be slowdown happening, more obvious observing the typical Q/Q TTM Revenue increase what is better at6.25% Matteo Mancini wrote.
The momentum was even higher from the previous reporting period showed at 2.73 % jump from $13046 millions in twelve months ending a quarter before.
In the Healthcare sector 87 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 703, from total ranking in previous quarter at 978. |
| Revenue TTM Q/Q Growth Statistics |
| High |
Average |
Low |
71.7 % |
6.25 % |
-25.07 % |
|
|
|
|
|
| Revenue TTM Y/Y Growth Statistics |
| High |
Average |
Low |
71.7 % |
6.25 % |
-25.07 % |
|
|
|
| Revenue TTM Q/Q Growth Company Ranking |
| Within: |
No. |
| Industry |
# 36 |
| Sector |
# 104 |
| S&P 500 |
# 951 |
|
| Cumulative Revenue growth
Comment |
Boston Scientific saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 8.7% year on year, to $ 13,402 millions if the fiscal year would have ended in Jun 30 2023.
Boston Scientific's trailing twelve months Revenue growth was higher than company's average 6.25% and higher than 7.27% growth in Mar 31 2023.
But sequential growth rate was less at 2.73 % from $13046 millions achieved in twelve months ending a quarter Mar 31 2023 Matteo Mancini continued.
There is slowdown happening, more noticeable as we look at average sequential historic rise that is stronger at6.25%.
The growth was much stronger sequentially showed at 2.73 % increase from $13046 millions in twelve months ending a quarter Mar 31 2023.
In the Healthcare sector 87 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 703, from total ranking in previous quarter at 978. |
| Revenue TTM Q/Q Growth Statistics |
| High |
Average |
Low |
71.7 % |
6.25 % |
-25.07 % |
|
|
|
| Revenue TTM Y/Y Growth Statistics |
| High |
Average |
Low |
71.7 % |
6.25 % |
-25.07 % |
|
|
|
| Revenue TTM Q/Q Growth Company Ranking |
| Within: |
No. |
| Industry |
# 36 |
| Sector |
# 104 |
| S&P 500 |
# 951 |
|
18.95%